Neural transplantation for the treatment of Parkinson's disease

被引：252

作者：

Björklund, A

Dunnett, SB

Brundin, P

Stoessl, AJ

Freed, CR

Breeze, RE

Levivier, M

Peschanski, M

Studer, L

Barker, R

机构：

[1] Lund Univ, Wallenberg Neurosci Ctr, Neurobiol Sect, S-22100 Lund, Sweden

[2] Cardiff Univ, Sch Biosci, Brain Repair Grp, Cardiff, S Glam, Wales

[3] Lund Univ, Dept Physiol Sci, Wallenberg Neurosci Ctr, Sect Neuronal Survival, S-22100 Lund, Sweden

[4] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC V5Z 1M9, Canada

[5] Univ Colorado, Sch Med, Dept Med, Denver, CO USA

[6] Univ Colorado, Sch Med, Dept Neurosurg, Denver, CO USA

[7] Free Univ Brussels, Hop Erasme, Serv Neurochirurg, B-1070 Brussels, Belgium

[8] Fac Med, INSERM, U421, Creteil, France

[9] Sloan Kettering Inst, Div Neurosurg, New York, NY USA

[10] Sloan Kettering Inst, Dev Biol Program, New York, NY USA

[11] Cambridge Ctr Brain Repair, Cambridge, England

来源：

LANCET NEUROLOGY | 2003年 / 2卷 / 07期

关键词：

D O I：

10.1016/S1474-4422(03)00442-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：437 / 445

页数：9

共 64 条

[1] The potential for circuit reconstruction by expanded neural precursor cells explored through porcine xenografts in a rat model of Parkinson's disease
Armstrong, RJE
Hurelbrink, CB
Tyers, P
Ratcliffe, EL
Richards, A
Dunnett, SB
Rosser, AE
Barker, RA
[J]. EXPERIMENTAL NEUROLOGY, 2002, 175 (01) : 98 - 111
[2] Porcine neural xenografts in the immunocompetent rat: Immune response following grafting of expanded neural precursor cells
Armstrong, RJE
Harrower, TP
Hurelbrink, CB
McLaughin, M
Ratcliffe, EL
Tyers, P
Richards, A
Dunnett, SB
Rosser, AE
Barker, RA
[J]. NEUROSCIENCE, 2001, 106 (01) : 201 - 216
[3] Xenogeneic transplantation
Auchincloss, H
Sachs, DH
[J]. ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 433 - 470
[4] Porcine neural xenografts: what are the issues?
Barker, RA
[J]. NEURAL TRANSPLANTATION IN NEURODEGENERATIVE DISEASE: CURRENT STATUS AND NEW DIRECTIONS, 2000, 231 : 184 - 196
[5] Neural tissue xenotransplantation: What is needed prior to clinical trials in Parkinson's disease?
Barker, RA
Kendall, AL
Widner, H
[J]. CELL TRANSPLANTATION, 2000, 9 (02) : 235 - 246
[6] A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease
Barker, RA
Ratcliffe, E
Mclaughlin, M
Richards, A
Dunnett, SB
[J]. JOURNAL OF NEUROSCIENCE, 2000, 20 (09) : 3415 - 3424
[7] Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model
Björklund, LM
Sánchez-Pernaute, R
Chung, SM
Andersson, T
Chen, IYC
McNaught, KS
Brownell, AL
Jenkins, BG
Wahlestedt, C
Kim, KS
Isacson, O
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) : 2344 - 2349
[8] Bozoki A, 2004, NEUROLOGY, V62, pA126
[9] Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease
Brundin, P
Pogarell, O
Hagell, P
Piccini, P
Widner, H
Schrag, A
Kupsch, A
Crabb, L
Odin, P
Gustavii, B
Björklund, A
Brooks, DJ
Marsden, CD
Oertel, WH
Quinn, NP
Rehncrona, S
Lindvall, O
[J]. BRAIN, 2000, 123 : 1380 - 1390
[10] Parthenogenetic stem cells in nonhuman primates
Cibelli, Jose B.
Grant, Kathleen A.
Chapman, Karen B.
Cunniff, Kerrianne
Worst, Travis
Green, Heather L.
Walker, Stephen J.
Gutin, Philip H.
Vilner, Lucy
Tabar, Viviane
Dominko, Tanja
Kane, Jeff
Wettstein, Peter J.
Lanza, Robert P.
Studer, Lorenz
Vrana, Kent E.
West, Michael D.
[J]. Science, 2002, 295 (5556)

← 1 2 3 4 5 6 7 →